Filing Details
- Accession Number:
- 0001415889-22-003247
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-03-21 21:58:12
- Reporting Period:
- 2022-03-17
- Accepted Time:
- 2022-03-21 21:58:12
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1023024 | Ani Pharmaceuticals Inc | ANIP | Pharmaceutical Preparations (2834) | 582301143 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1870913 | Muthusamy Shanmugam | C/O Ani Pharmaceuticals, Inc. 210 Main Street West Baudette MN 56623 | Head Of R&D, Coo-Novitium Ops | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-03-17 | 5,000 | $27.65 | 18,460 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2022-03-17 | 5,000 | $27.65 | 5,000 | No | 4 | P | Indirect | Held by SS Pharma LLC |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Indirect | Held by SS Pharma LLC |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 1,332,620 | Indirect | Held by Esjay LLC |
Footnotes
- The shares were acquired in multiple trades at prices ranging from $27.36 to $28.00. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
- The Reporting Person holds voting and dispositive power over the shares held by SS Pharma LLC.
- The Reporting Person holds voting and dispositive power over the shares held by Esjay LLC.